retatrutide eye side effects Effects: What Clinical Trials Tell Us Retatrutide Long-Term Side Effects: What

In a Phase 2b study in people with type 2 diabetes and obesity over 54 weeks, treatment with cotadutide at doses of 100-300 g daily improved some non-invasive markers of NAFLD such as transaminase levels, the FIB-4 index, fatty liver disease fibrosis score (NFS) and fatty liver index (FLI) but fatty liver disease was not assessed directly with liver biopsy

Results Maternal immune activation mice exhibited impaired social interaction, decreased communication, and repetitive behavior Current epidemiological evidence suggests that maternal immune activation (MIA) secondary to infection during pregnancy may be an environmental risk factor predisposing towards the development of ASD [3, 34, 35, 36, 37, 38]

Discontinuation rates were higher than in Phase 2 trials - 18.2% at the 12mg dose versus 4% with placebo

He is the editorial director of Perio-Implant Advisory and serves on the editorial advisory board of Dental Economics